NaPro BioTherapeutics, Inc. 4840 Pearl East Circle, #300W Boulder, Colorado 80301
NaPro BioTherapeutics, Inc., is a life science company focused in two distinct therapeutic areas: the development of proprietary anti-cancer agents and the development of genomic therapies for inherited disease, primarily through the use of our novel "gene editing" technology.
Email: info@naprobio.com
Nektar Therapeutics San Carlos, California
Nektar Therapeutics (NASDAQ:NKTR) provides a portfolio of leading drug delivery solutions that enable the development of high-value pharmaceutical products.
Formed through the fusion of Inhale Therapeutic Systems, Shearwater, and Bradford Particle Design, our company offers a suite of leading drug delivery technologies that encompasses molecule engineering including advanced pegylation, particle engineering comprising both pulmonary particle technology and supercritical fluid technology (SCF), and advanced drug delivery solutions for oral, injectable, and pulmonary administration.
NeoGenesis Pharmaceuticals, Inc. 840 Memorial Drive Camgridge, Massachusetts 02139
NeoGenesis Pharmaceuticals, Inc. is a drug discovery company focused on using its proprietary drug discovery technologies to discover and develop a portfolio of small molecule-based drugs, both for itself and for its collaboration partners. The company's universal, unbiased, affinity-based technologies, coupled with millions of diverse medicinally relevant compounds, provide an unmatched efficiency in lead discovery and optimization. NeoGenesis' core technology, the Automated Ligand Identification System (ALIS), is a rapid and universal affinity-based system for identifying and optimizing novel drug leads. Coupled with the company's NeoMorph compound library, consisting of more than 10 million diverse medicinally relevant small molecules, ALIS enables the identification of novel and selective drug leads against validated and emerging new genomic targets. Email: info@neogenesis.com
NeoRx Corporation 300 Elliott Avenue West, Suite 500 Seattle, Washington 98119
NeoRx is a cancer therapeutics company developing products for targeted delivery of anti-cancer agents, including radiopharmaceuticals, to tumor sites. Email: IR@neorx.com
Neurion Pharmaceuticals, Inc. 180 North Vinedo Avenue Pasadena, California 91107
Neurion Pharmaceuticals, Inc. is a privately held, development-stage pharmaceutical company that is focused on the discovery of novel drugs for central nervous system (CNS) diseases and other disorders associated with ion channels. The Company uses its proprietary discovery platform technology to understand the structural basis of drug-ion channel interactions, and to design safer and more effective drugs by exploiting this knowledge. Email: billr@neurionpharma.com
Neurocrine Biosciences, Inc. San Diego, California
Neurocrine Biosciences is a biopharmaceutical company focused on the discovery and development of novel therapeutics for neuropsychiatric, neuroinflammatory and neurodegenerative diseases and disorders. The Company's neuroscience, endocrine and immunology disciplines provide a unique biological understanding of the molecular interaction between central nervous, immune and endocrine systems for the development of therapeutic interventions for anxiety, depression, multiple sclerosis, insomnia, brain cancer, obesity and diabetes.
Novartis Pharmaceuticals New York, New York
Novartis is a global company that touches your life in ways you might not have imagined. Our employees make products that range from life-saving drugs for organ transplantation to state-of-the-art contact lenses, from affordable generic medicines to a famous name in baby food, from trusted over-the-counter brands against the common cold to products that protect farm animals and your beloved pets from parasites and disease. What do these business areas have in common? They are all powered by science and innovation. Novartis invests approximately 4 billion Swiss francs every year in research and development. We are exploring new scientific horizons and applying the latest technologies to lead future breakthroughs.
Novo Nordisk Plantation, Florida
Novo Nordisk is a focused healthcare company. With the broadest diabetes product portfolio in the industry, including the most advanced products within the area of insulin delivery systems, Novo Nordisk is the world leader in diabetes care. In addition, Novo Nordisk has a leading position in areas such as haemostasis management, growth disorders and hormone replacement therapy. Novo Nordisk manufactures and markets pharmaceutical products and services that make a significant difference to patients, the medical profession and society.
NPS Pharmaceuticals Salt Lake City, Utah
NPS Pharmaceuticals is engaged in the discovery and development, and is preparing for the commercialization of therapeutic small molecules and recombinant proteins.
Current product candidates include treatments for bone and mineral disorders (osteoporosis & hyperparathyroidism), gastrointestinal disorders (GI) and central nervous system disorders (CNS). Our objective is to build a profitable company by using our scientific development and marketing expertise, which will allow us and the patients who use our drugs, to reap the value of our efforts. We are creating a diversified pipeline of products in all stages of development from discovery research, to preclinical testing, to clinical trials.
Nymox 230 West Passaic Street Maywood, New Jersey 07607
Nymox Pharmaceutical Corporation is a biopharmaceutical company based in Maywood, New Jersey and Saint Laurent, Quebec. It has two subsidiaries, Nymox Corporation and Serex, Inc.
Nymox specializes in the research and development of therapeutics and diagnostics for the aging population with an emphasis on Alzheimer's disease.
Nymox was incorporated in 1989 and became a public company in 1995. Nymox was founded around a group of distinguished career scientists with long established interests in brain diseases and Alzheimer’s disease in particular.
Nymox is the first company to have successfully developed an accurate peripheral test for this devastating disorder, the AlzheimAlert™ test. Nymox’s strong scientific relationships have led to the development every year of at least one major new project initiative. Nymox currently markets its AlzheimAlert™ test to physicians in the U.S. and its NicAlert™ test for tobacco exposure both in the U.S. and Japan. Nymox has an exciting pipeline of drugs in development and a proprietary antimicrobial treatment against deadly E. coli contamination. Nymox also has a line of other “Alert” products (such as OsteoAlert™ for osteoporosis) in development, as well as a unique proprietary diagnostic platform technology. Email: info@nymox.com
Public
Feeds 
